Your browser doesn't support javascript.
loading
Primary resistance to integrase inhibitors in Shenzhen.
Zhu, Yue; Huang, Yuanmei; Zheng, Chenli; Tang, Jie; Zeng, Guang; Xie, Wei; Wang, Hui; Zhang, Lukun; Liu, Shaochu; Zhang, Yan; Tan, Wei; Tan, Jingguang; Jiang, Lijuan; He, Yun; Xu, Liumei; Yang, Zhengrong; Zhao, Jin.
Afiliação
  • Zhu Y; School of Public Health, Shantou University, Shantou, China.
  • Huang Y; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Zheng C; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Tang J; School of Public Health, Shanxi Medical University, Taiyuan, China.
  • Zeng G; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Xie W; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Wang H; School of Public Health, University of South China, Hengyang, China.
  • Zhang L; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Liu S; School of Public Health, University of South China, Hengyang, China.
  • Zhang Y; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Tan W; Department of Infectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, China.
  • Tan J; Department of Infectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, China.
  • Jiang L; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • He Y; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Xu L; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Yang Z; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Zhao J; Department of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
J Antimicrob Chemother ; 78(2): 546-549, 2023 02 01.
Article em En | MEDLINE | ID: mdl-36585770
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Inibidores de Integrase de HIV / Integrase de HIV / Fármacos Anti-HIV / Farmacorresistência Viral Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Inibidores de Integrase de HIV / Integrase de HIV / Fármacos Anti-HIV / Farmacorresistência Viral Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China